Related Experiment Video
Updated: May 30, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Clin-STAR Corner: Rehabilitation for Older Adults With Heart Failure
Mariana Wingood1,2, Jennifer L Vincenzo3,4, Parag Goyal5
1Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Abstract:
Heart failure is a major contributor to morbidity, mortality, and healthcare costs, especially among older adults. Despite a large body of evidence supporting the benefits of cardiac rehabilitation, less than 30% of eligible Medicare beneficiaries participate in cardiac rehabilitation. Thus, it is essential to examine alternatives, such as physical rehabilitation, a rehabilitation approach that focuses on physical activity and function. We systematically identified and summarized four key articles published between 2022 and 2024 that highlight innovations in rehabilitation with the potential of increasing utilization. These articles emphasize three areas of opportunity: (1) home-based telerehabilitation; (2) research focused on underrepresented and underserved populations; and (3) economic evaluations. Additional research on alternative modes of cardiac or physical rehabilitation, strategies to address heart failure-related health inequities, and implementation studies incorporating cost-effectiveness are needed to support increased utilization of cardiac and physical rehabilitation.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics
Restorative Care
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers